NCT07664501Not yet recruiting
The Simplified Total-body Resistance Exercise for Muscular Hypertrophy for Diabetic Population (D-STORM)
The Simplified Total-body Resistance Exercise for Muscular Hypertrophy for Diabetic Population (D-STORM): Rationale and Study Protocol for a Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 25 Jun 2026
Brief summary (registry, in English)
Type 2 diabetes is associated with progressive loss of muscle mass, which worsens blood sugar control and increases the risk of heart disease and disability. Resistance training (weight training) has been shown to build muscle and improve blood sugar levels, but most existing programmes use high intensities that are difficult for older or inactive people with diabetes to sustain. This study tests a new resistance training programme called D-STORM (Simplified Total-body Resistance Exercise for Muscular Hypertrophy for Diabetic Population), which uses a lower, more manageable training load designed to be safe, tolerable, and effective for adults with Type 2 diabetes who are not on insulin. Participants will be randomly assigned to either twice-weekly D-STORM training plus their usual diabetes care, or usual care alone, for 12 weeks. The main outcome measured is change in HbA1c (a blood test reflecting average blood sugar over 3 months). Body composition, walking capacity, blood pressure, heart rate, and quality of life will also be measured.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 56 (estimated)
- First submitted
- 17 Jun 2026
- Start date
- 1 Jan 2027
- Primary completion date
- 30 Sept 2027
- Lead sponsor
- Universiti Teknologi Mara
- Diseases
- Type 2 diabetes
- NCT number
- NCT07664501
What you commit to
- Study type: Interventional
- Planned participants: 56
- From 1 Jan 2027 to the primary completion date, 30 Sept 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Currently on insulin therapy
Other illness
- Serious medical conditions that would prevent safe participation in an exercise programme
- Underlying conditions that would not allow safe participation in the exercise intervention
Lab values
- HbA1c below 6.5% or above 13.0%
Age
- Age below 18 or above 65 years
Other
- Blood pressure 160/100 mmHg or higher at screening
- Pregnant or planning to become pregnant within the next 6 months
- Any physical or functional limitation that would prevent participation in resistance training
Who the study is looking for
- Aged 18 to 65 years
- Confirmed diagnosis of Type 2 Diabetes Mellitus
- HbA1c between 6.5% and 13.0%
- Not currently on insulin therapy
- Has a primary care provider
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Sultan Al-Abdullah (HASA) Coordinator of this site? Confirm its status | Kuala Selangor | Malaysia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.